国金证券：创新药有望获得更高利润空间

Group 1 - The core viewpoint of the article emphasizes that the recent press conference and series of discussions held by the Medical Insurance Bureau clarify future policies that support enterprises in "anti-involution," overseas expansion, and differentiated innovation, which is beneficial for the high-quality development of the medical device industry [1] - The enthusiasm for innovation and research and development among enterprises is expected to be stimulated, leading to a gradual stabilization of profit margins for leading companies in niche segments [1] - Innovative products are anticipated to achieve higher profit margins, and the domestic market growth rate is expected to recover rapidly [1]